Interest of the Manual Exploration as a Supplement to the Coelioscopy in the Evaluation of the Resectability of Peritoneal Carcinosis
CARPEMAN
1 other identifier
interventional
40
1 country
5
Brief Summary
This is a Multicenter prospective diagnostic study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2015
Longer than P75 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2015
CompletedFirst Posted
Study publicly available on registry
July 10, 2015
CompletedStudy Start
First participant enrolled
September 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2019
CompletedJuly 9, 2019
July 1, 2019
3.8 years
June 26, 2015
July 8, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
evaluate the number of patients with or without laparotomy after evaluation of the resectability by coelioscopy and coelioscopy more manual exploration
1 month after inclusion
Secondary Outcomes (2)
Number of patients with complications (eventrations, infections, pains) after manual exploration
1 month after inclusion
Number of patients with parietal metastases
1 month after inclusion
Study Arms (1)
manual exploration by GelPort
EXPERIMENTALmanual exploration in supplement of coelioscopy before laparotomy
Interventions
Manual exploration of the peritoneal carcinosis by the system GelPort ® with calculation of peritoneal cancer index for evaluation of the resectability
laparotomy will be performed if indication confirmed by manual exploration
Eligibility Criteria
You may qualify if:
- Over 18 years of age Patient
- Woman presenting a peritoneal carcinosis presumed ovarian origin
- Coelioscopy (1st intent or recurrence) planned or performed in the last 4 weeks for laparotomy. The peritoneal cancer index of Sugarbaker must be available.
- WHO 0 - 2
- Membership in a social security system
- Patient having given her written consent
You may not qualify if:
- Male
- Contraindication in the coelioscopy
- Any associated medical or psychological condition which could compromise the capacity of the patient to participate in the study
- Patient deprived of freedom, under guardianship or guardianship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
CHU
Amiens, France
Centre Françis Baclesse
Caen, France
CHU
Caen, France
Institut de Cancérologie de l'Ouest
Nantes, France
Centre Henri Becquerel
Rouen, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 26, 2015
First Posted
July 10, 2015
Study Start
September 1, 2015
Primary Completion
July 1, 2019
Study Completion
July 1, 2019
Last Updated
July 9, 2019
Record last verified: 2019-07